cancer - search results

Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.

Following global cancer prevention recommendations reduces the risk of developing the disease according to latest study.

JoAnne S Richards, PhD, Professor at Baylor College of Medicine, explores ovarian cancer research with a focus on ovarian function and dysfunction.

UCL and the University of Exeter find that long COVID fatigue has a more profound impact on the daily lives of patients compared to certain cancers.

With the potential to revolutionise medical diagnostics, a breathalyser using quantum laser-based technology could diagnose illness from exhaled breath.

A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.

Washington University School of Medicine researchers have identified four important symptoms of colorectal cancer that indicate elevated risk.

Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.

Early cancer treatment is vital to sustaining high cancer survival rates, but could AI improve clinician capabilities and predict worse cases?

Sonoenhancement with Acoustic Cluster Therapy (ACT®) improves drug delivery to solid tumors, and by that reduces the necessary doses and side effects.

Research finds that men who have a neurodevelopmental disorder, such as autism and ADHD, also have a slightly increased risk of testicular cancer.

Lester Litchfield, Head of Data Science at Volpara Health, discusses the future of artificial intelligence in breast health.

NHS England has published a one-year cancer survival index, showing how cancer survival rates have improved across the country by almost 10%.

Peter J. Houghton received his Ph.D. from the University of London (Institute of Cancer Research) 1977 He joined the faculty of St. Jude Children's Research Hospital in Memphis Tennessee and became Chair of Molecular Pharmacology (1992-2009) and co-lead for the Solid Malignancies Program (1988-2009). Dr. Houghton became Director, Childhood Cancer and...

Suspected cancer patients in England are currently referred to the NHS urgent cancer referral pathway, known as the ‘2-week wait’ (2WW). It guarantees that suspected cancer patients can see a specialist in Secondary Care within 14 days of referral.

Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.

Dr. Eric O. Freed received his Ph.D. in 1990 from the University of Wisconsin-Madison His Ph.D. work focused on the function of the murine leukemia virus and HIV envelope glycoproteins in membrane fusion and virus entry. He joined the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH...

AI offers an opportunity to reimagine our approach to cancer diagnostics, leveraging data to build a more robust and efficient system for cancer referrals.

The Department of Molecular Medicine provides an interdisciplinary program of study in the areas of cancer and aging and their prevention.

Pancreatic cancer rates are trending upwards for both sexes, with younger women and Black women seeing the steepest increase.